Allergan Deal Gets Compounder To Say Drugs Not FDA-OK'd
Allergan Inc.'s aggressive bid to block sales of lower-cost compounded drugs has ended with a compounder's agreement to tell customers that its products aren't approved by the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article